SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : RXSD Rexall Sundown -- Ignore unavailable to you. Want to Upgrade?


To: Dorine Essey who wrote (54)8/5/1998 3:29:00 PM
From: john q  Read Replies (1) | Respond to of 327
 
Second news release:

Rexall says on track to hit record earnings
BOCA RATON, Fla., Aug 5 (Reuters) - Rexall Sundown Inc. said Wednesday the company remains on track to deliver record revenues and earnings despite bellwether General Nutrition Cos. Inc.'s (GNCI - news) decision Tuesday to slash its prices on some products, causing most vitamin companies' stocks to dip.
Rexall said in a statement that its stock's Tuesday decline to 21-3/4, its lowest point since November 1997, was due to General Nutrition's decision to cut prices up to 40 percent on selected groups of basic vitamins and up to 20 percent on its sports nutritional supplements amid stiff competition.

However, Rexall said the decision does not negatively impact the growth prospects of the vitamin and nutritional supplement industry or on the strength of Rexall Sundown, which also makes and markets vitamins and nutritional supplements.

First Call expects the company to post fiscal year earnings of $0.95 per share and fourth quarter earnings of $0.28 per share. In fiscal 1997, the company posted earnings of $1.03 per share on revenue of $263.4 million. In the year-ago fourth quarter, Rexall posted earnings of $0.29 per share on revenues of $79.2 million.

Yet, a puzzling reaction to the news - must be the dow, and the market makers driving the price down. I did get in Dorine and also got some calls also...doc